Moderna and Merck announce promising melanoma vaccine

Moderna and Merck are developing an mRNA vaccine tailored to patients' tumors.

Published 2j4 sources✓ ConfirmedImportantupdated 1j

≈ 14sSpeed

The fact

This treatment could protect against melanoma recurrences.

If approved, it will mark a major breakthrough in oncology.

4 sources — click a link to read an article on the topic:

Explore this topic

Auto-synthesis from 4 media sources · identified on August 20, 2026